Abuzakuk T, Senthil K V, Shenava Y, Bulstrode C, Skinner JA, Cannon SR, et al. Autotransfusion drains in total knee replacement. Are they alternatives to homologous transfusion? International Orthopaedics. 2007;31(2):235–239. [PMC free article: PMC2267563] [PubMed: 16761149]

Adams ES, Longhurst CA, Pageler N, Widen E, Franzon D, Cornfield DN. Computerized physician order entry with decision support decreases blood transfusions in children. Pediatrics. 2011;127(5):e1112–e1119. [PubMed: 21502229]

Adams KW, Tolich D. Blood transfusion: the patient's experience. American Journal of Nursing. 2011;111(9):24–2. [PubMed: 21844792]

Ades AE, Caldwell DM, Reken S, Welton NJ, Sutton AJ, Dias S. NICE DSU technical support document 7: evidence synthesis of treatment efficacy in decision making: a reviewer's checklist. 2012. Available from: http://www​.nicedsu.org.uk/ [PubMed: 27905719]

Aghdaii N, Kabiri M, Yazdanian F, Ghaffarinejad MH. Effect of retransfusion of heparin remaining in the salvaged blood on postoperative blood loss in coronary artery bypass grafting: Comparison with homologous blood transfusion (running title: Postoperative blood loss in CABG). Iranian Heart Journal. 2012;13(2):24–34.

Aguilera X, Martinez-Zapata MJ, Bosch A, Urrutia G, Gonzalez JC, Jordan M, et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. Journal of Bone and Joint Surgery American Volume. 2013;95(22):2001–2007. [PubMed: 24257657]

Ahn SW, Shim JK, Youn YN, Song JW, Yang SY, Chung SC, et al. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circulation Journal. 2012;76(1):96–101. [PubMed: 22033349]

Alizadeh Ghavidel A, Totonchi Z, Chitsazan M, Gholampour Dehaki M, Jalili F, Farsad F, et al. Safety and efficacy of caproamin fides and tranexamic Acid versus placebo in patients undergoing coronary artery revascularization. Journal of Cardiovascular and Thoracic Research. 2014;6(3):197–202. [PMC free article: PMC4195972] [PubMed: 25320669]

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). Journal of Bone and Joint Surgery American Volume. 2013;95(21):1969–1974. [PubMed: 24196467]

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). Journal of Bone and Joint Surgery American Volume. 2013;95(21):1961–1968. [PubMed: 24196466]

Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion. 2008;48(3):519–525. [PubMed: 18067499]

Amin A, Watson A, Mangwani J, Nawabi D, Ahluwalia R, Loeffler M. A prospective randomised controlled trial of autologous retransfusion in total knee replacement. Journal of Bone and Joint Surgery British Volume. 2008;90(4):451–454. [PubMed: 18378918]

Andreasen JJ, Nielsen C. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. European Journal of Cardio-Thoracic Surgery. 2004;26(2):311–317. [PubMed: 15296889]

Armellin G, Casella S, Guzzinati S, Pasini L, Marcassa A, Giron G. Tranexamic acid in aortic valve replacement. Journal of Cardiothoracic and Vascular Anesthesia. 2001;15(3):331–335. [PubMed: 11426364]

Askeland RW, McGrane S, Levitt JS, Dane SK, Greene DL, Vandeberg JA, et al. Improving transfusion safety: implementation of a comprehensive computerized bar code-based tracking system for detecting and preventing errors. Transfusion. 2008;48(7):1308–1317. [PubMed: 18346018]

Atay EF, Guven M, Altintas F, Kadioglu B, Ceviz E, Ipek S. Allogeneic blood transfusion decreases with postoperative autotransfusion in hip and knee arthroplasty. Acta Orthopaedica Et Traumatologica Turcica. 2010;44(4):306–312. [PubMed: 21252608]

Aufricht C, Ties M, Wimmer M, Haschke F, Pietschnig B, Herkner K. Iron supplementation in children after cardiopulmonary bypass for surgical repair of congenital heart disease. Pediatric Cardiology. 1994;15(4):167–169. [PubMed: 7991433]

Baric D, Biocina B, Unic D, Sutlic Z, Rudez I, Vrca VB, et al. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study. European Journal of Cardio-Thoracic Surgery. 2007;31(3):366–371. [PubMed: 17218108]

Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. Journal of Bone and Joint Surgery British Volume. 1996;78(3):434–440. [PubMed: 8636182]

Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthopaedica Scandinavica. 2001;72(5):442–448. [PubMed: 11728069]

Benoni G, Lethagen S, Nilsson P, Fredin H. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthopaedica Scandinavica. 2000;71(3):250–254. [PubMed: 10919295]

Bidolegui F, Arce G, Lugones A, Pereira S, Vindver G. Tranexamic acid reduces blood loss and transfusion in patients undergoing total knee arthroplasty without tourniquet: a prospective randomized controlled trial. Open Orthopaedics Journal. 2014;8:250–254. [PMC free article: PMC4133924] [PubMed: 25132872]

Bisbe E, Molto L, Arroyo R, Muniesa JM, Tejero M. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. British Journal of Anaesthesia. 2014;113(3):402–409. [PubMed: 24780615]

Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. British Journal of Surgery. 1986;73(10):783–785. [PubMed: 3533203]

Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 1994;108(6):1083–1091. [PubMed: 7527112]

Boese CK, Gallo TJ, Weis M, Baker R, Plantikow CJ, Cooley B. Efficacy and cost-effectiveness of a blood salvage system in primary total knee arthroplasty: a retrospective match-controlled chart review. Iowa Orthopaedic Journal. 2011;31:78–82. United States. [PMC free article: PMC3215119] [PubMed: 22096425]

Bolton-Maggs PHB, Poles D, Watt A, Thomas D. The 2013 SHOT annual report. 2014. Available from: http://www​.shotuk.org.

Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070–1077. [PubMed: 10532600]

Bradshaw AR, Monoghan J, Campbell D. Oral tranexamic acid reduces blood loss in total knee replacement arthroplasty. Current Orthopaedic Practice. 2012;23(3):209–212.

British Committe for Standards in Haematology. Guideline on the administration of blood components. 2009. Available from: http://www​.bcshguidelines​.com/documents/Admin​_blood_components_bcsh_05012010.pdf.

Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LB, Kenler HA, et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Archives of Surgery. 1998;133(7):740–744. [PubMed: 9688002]

Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. American Journal of Surgery. 1997;174(2):143–148. [PubMed: 9293831]

Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2008;137(2):227–231. [PubMed: 17499419]

Campbell HE, Estcourt LJ, Stokes EA, Llewelyn CA, Murphy MF, Wood EM, et al. Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial. Transfusion. 2014;54(10):2394–2403. [PubMed: 24826894]

Campbell J, Holland C, Richens D, Skinner H. Impact of cell salvage during cardiac surgery on the thrombelastomeric coagulation profile: a pilot study. Perfusion. 2012;27(3):221–224. [PubMed: 22185951]

Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet. 1993;341(8855):1227–1232. [PubMed: 8098389]

Canan CE, Myers JA, Owens RK, Crawford CH, Djurasovic M, Burke LO, et al. Blood salvage produces higher total blood product costs in single-level lumbar spine surgery. Spine. 2013;38(8):703–708. [PubMed: 23044618]

Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2010;(4) CD001888. [PMC free article: PMC4163967] [PubMed: 20393932]

Carson JL, Chen AY. In search of the transfusion trigger. Clinical Orthopaedics and Related Research. 1998;(357):30–35. [PubMed: 9917697]

Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. American Heart Journal. 2013;165(6):964–971. [PMC free article: PMC3664840] [PubMed: 23708168]

Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews. 2012;(4) CD002042. [PMC free article: PMC4171966] [PubMed: 22513904]

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine. 2011;365(26):2453–2462. [PMC free article: PMC3268062] [PubMed: 22168590]

Casati V, Bellotti F, Gerli C, Franco A, Oppizzi M, Cossolini M, et al. Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesiology. 2001;94(1):8–14. [PubMed: 11135716]

Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P, et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. Journal of Thoracic and Cardiovascular Surgery. 2004;128(1):83–91. [PubMed: 15224025]

Chan JCW, Chu RW, Young BWY, Chan F, Chow CC, Pang WC, et al. Use of an electronic barcode system for patient identification during blood transfusion: 3-year experience in a regional hospital. Hong Kong Medical Journal. 2004;10(3):166–171. [PubMed: 15181220]

Chan T, Eckert K, Venesoen P, Leslie K, Chin-Yee I. Consenting to blood: what do patients remember? Transfusion Medicine. 2005;15(6):461–466. [PubMed: 16359416]

Chang CS, Lin YC, Wu YC, Yeh CJ, Lin YC. The effects of a computerized transfusion decision support system on physician compliance and its appropriateness for fresh frozen plasma use in a medical center. American Journal of Clinical Pathology. 2011;135(3):417–422. [PubMed: 21350096]

Chang CS, Lin YC, Lin CC, Yeh CJ, Wu YC, Lin YC. The physician compliance of red blood cell transfusion by computerized transfusion decision support system. Kaohsiung Journal of Medical Sciences. 2012;28(6):331–335. [PubMed: 22632889]

Chareancholvanich K, Siriwattanasakul P, Narkbunnam R, Pornrattanamaneewong C. Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskeletal Disorders. 2012;13:124. [PMC free article: PMC3416573] [PubMed: 22817651]

Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clinical Orthopaedics and Related Research. 2011;469(10):2874–2880. [PMC free article: PMC3171556] [PubMed: 21512813]

Chauhan S, Bisoi A, Modi R, Gharde P, Rajesh MR. Tranexamic acid in paediatric cardiac surgery. Indian Journal of Medical Research. 2003;118:86–89. [PubMed: 14680204]

Chen JH, Fang DZ, Tim GL, Evans KH, Lee PM, Shieh L. Why providers transfuse blood products outside recommended guidelines in spite of integrated electronic best practice alerts. Journal of Hospital Medicine. 2015;10(1):1–7. [PubMed: 25044190]

Cheng SC, Hung TS, Tse PY. Investigation of the use of drained blood reinfusion after total knee arthroplasty: a prospective randomised controlled study. Journal of Orthopaedic Surgery. 2005;13(2):120–124. [PubMed: 16131672]

Cheung D, Lieberman L, Lin Y, Callum J. Consent for blood transfusion: do patients understand the risks and benefits? Transfusion Medicine (Oxford, England). 2014;24(5):269–273. [PubMed: 25066199]

Cholette J, Powers K, Alfieris G, Angona R, Henrichs K, Blumberg N. Cell saver for volume replacement in children following cardiopulmonary bypass reduces the number of RBC and blood product transfusions and donor exposures. Critical Care Medicine. 2011;39:7.

Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. British Journal of Haematology. 2004;125(1):69–73. [PubMed: 15015971]

Christodoulakis M, Tsiftsis DD., Hellenic Surgical Oncology Perioperative EPO Study Group. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study. Annals of Surgical Oncology. 2005;12(9):718–725. [PubMed: 16052276]

Cip J, Widemschek M, Benesch T, Waibel R, Martin A. Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial. Clinical Orthopaedics and Related Research. 2013;471(4):1319–1325. [PMC free article: PMC3586038] [PubMed: 23229426]

Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chirurgica Belgica. 2007;107(4):397–401. [PubMed: 17966532]

Coffey A, Pittmam J, Halbrook H, Fehrenbacher J, Beckman D, Hormuth D. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. American Surgeon. 1995;61(7):566–568. [PubMed: 7793735]

Colomo A, Hernandez G, Muñiz-Diaz E, Madoz P, Aracil C, Alvarez-Urturi C. Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding. Hepatology. 2008;48(4 Suppl):413A.

Commercial Medicines Unit (CMU). Electronic market information tool (EMIT). 2013. [June 2014]. Available from: http://cmu​.dh.gov.uk​/electronic-market-information-tool-emit/

Cooper HA, Rao SV, Greenberg MD, Rumsey MP, McKenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). American Journal of Cardiology. 2011;108(8):1108–1111. [PubMed: 21791325]

Corbeau JJ, Monrigal JP, Jacob JP, Cottineau C, Moreau X, Bukowski JG, et al. Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery. Annales Francaises D'Anesthesie Et De Reanimation. 1995;14(2):154–161. [PubMed: 7486272]

Cottrell S, Davidson V. National audit of bedside transfusion practice. Nursing Standard. 2013;27(43):41–48. [PubMed: 23987720]

Court EL, Robinson JA, Hocken DB. Informed consent and patient understanding of blood transfusion. Transfusion Medicine. 2011;21(3):183–189. [PubMed: 21272102]

Craig J, Brown H, Eastgate J, Macpherson K, Wilson S. The use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. Understanding our advice: the use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. United Kingdom: Glasgow: NHS Quality Improvement Scotland (NHS QIS); 2006. Available from: http://www​.nhshealthquality.org.

Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ. 2011;343:d5701. [PMC free article: PMC3198510] [PubMed: 22012809]

Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart and Lung. 1994;23(6):493–499. [PubMed: 7852064]

Crotty B. Recycling blood: sharing the benefits of cell salvage. Applied Health Economics and Health Policy. 2006;5(1):5–10. [PubMed: 16774288]

Cuenca J, Garcia-Erce JA, Martinez F, Cardona R, Perez-Serrano L, Munoz M. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. International Journal of Surgery. 2007;5(2):89–94. [PubMed: 17448971]

Curtis L. Unit costs of health and social care. Kent: Personal Social Services Research Unit; 2013. Available from: http://www​.pssru.ac.uk​/project-pages/unit-costs/2013/index​.php?file=full.

D'Ambra MN, Gray RJ, Hillman R, Jones JW, Kim HC, Rawitscher R, et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Annals of Thoracic Surgery. 1997;64(6):1686–1693. [PubMed: 9436556]

Dakir A, Ramalingam B, Ebenezer V, Dhanavelu P. Efficacy of tranexamic acid in reducing blood loss during maxillofacial trauma surgery-a pilot study. Journal of Clinical and Diagnostic Research. 2014;8(5):ZC06–ZC08. [PMC free article: PMC4080055] [PubMed: 24995234]

Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesthesia and Analgesia. 2000;91(1):29–34. [PubMed: 10866882]

Damgaard S, Steinbruchel DA. Autotransfusion with cell saver for off-pump coronary artery bypass surgery: a randomized trial. Scandinavian Cardiovascular Journal. 2006;40(3):194–198. [PubMed: 16798668]

Davies A, Staves J, Kay J, Casbard A, Murphy MF. End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion. 2006;46(3):352–364. [PubMed: 16533276]

Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: A systematic review and economic model. Health Technology Assessment. 2006;10(44):1–114. [PubMed: 17049141]

Davis R, Murphy MF, Sud A, Noel S, Moss R, Asgheddi M, et al. Patient involvement in blood transfusion safety: patients' and healthcare professionals' perspective. Transfusion Medicine. 2012;22(4):251–256. [PubMed: 22519365]

de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. American Journal of Orthopedics. 1996;25(8):533–542. [PubMed: 8871751]

De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. Journal of Thoracic and Cardiovascular Surgery. 2000;119(3):575–580. [PubMed: 10694619]

de Gast-Bakker DH, de Wilde RBP, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, et al. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. Intensive Care Medicine. 2013;39(11):2011–2019. [PubMed: 23995984]

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, et al. Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. Heart, Lung and Circulation. 2012;21(11):706–710. [PubMed: 22842057]

Devon KM, McLeod RS. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database of Systematic Reviews. 2009;(1) CD007148. [PubMed: 19160325]

DeYoung KT, Vu T. Examining the evidence for frequency of vital sign monitoring during transfusion of blood products in the stem cell transplant patient population. Biology of Blood and Marrow Transplantation. 2013;19(2 Suppl 1):S359.

Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. 2011. Available from: http://www​.nicedsu.org.uk. [PubMed: 27466657]

Diedrich B, Remberger M, Shanwell A, Svahn BM, Ringden O. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 × 10(9) per L versus 30 × 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion. 2005;45(7):1064–1072. [PubMed: 15987349]

Diprose P, Herbertson MJ, O'Shaughnessy D, Deakin CD, Gill RS. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. British Journal of Anaesthesia. 2005;94(3):271–278. [PubMed: 15591329]

Dobosz B, Dutka J, Dutka L, Maleta P. Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. Ortopedia, Traumatologia, Rehabilitacja. 2012;14(5):421–428. [PubMed: 23208933]

Dousias V, Paraskevaidis E, Dalkalitsis N, Tsanadis G, Navrozoglou I, Lolis D. Recombinant human erythropoietin in mildly anemic women before total hysterectomy. Clinical and Experimental Obstetrics and Gynecology. 2003;30(4):235–238. [PubMed: 14664421]

Doussau A, Perez P, Puntous M, Calderon J, Jeanne M, Germain C, et al. Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study. Transfusion. 2014;54(4):1114–1124. [PubMed: 24117772]

Dowlatshahi D, Butcher KS, Asdaghi N, Nahirniak S, Bernbaum ML, Giulivi A, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke; a Journal of Cerebral Circulation. 2012;43(7):1812–1817. [PubMed: 22556194]

Dramis A, Plewes J. Autologous blood transfusion after primary unilateral total knee replacement surgery. Acta Orthopaedica Belgica. 2006;72(1):15–17. [PubMed: 16570888]

Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. British Journal of Surgery. 2009;96(10):1122–1128. [PubMed: 19731228]

Ellis MH, Fredman B, Zohar E, Ifrach N, Jedeikin R. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia. 2001;13(7):509–513. [PubMed: 11704449]

Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I, Hempelmann G. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesthesia and Analgesia. 2001;92(3):775–780. [PubMed: 11226117]

Esfandiari BR, Bistgani MM, Kabiri M. Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding. Asian Cardiovascular and Thoracic Annals. 2013;21(6):669–674. [PubMed: 24569324]

Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database of Systematic Reviews. 2012;(5) CD004269. [PubMed: 22592695]

European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines. 2013. Available from: http://www​.ema.europa​.eu/docs/en_GB/document_library​/Referrals_document​/IV_iron_31/WC500151308.pdf.

Fan YX, Liu FF, Jia M, Yang JJ, Shen JC, Zhu GM, et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Archives of Gerontology and Geriatrics. 2014;59(1):181–185. [PubMed: 24745810]

Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. Journal of Bone and Joint Surgery American Volume. 1996;78(1):62–72. [PubMed: 8550681]

Farrokhi MR, Kazemi AP, Eftekharian HR, Akbari K. Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: a randomized clinical trial. Journal of Neurosurgical Anesthesiology. 2011;23(4):290–296. [PubMed: 21836528]

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L. Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. Journal of Cardiothoracic Surgery. 2009;4:25. [PMC free article: PMC2706826] [PubMed: 19538741]

Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Annals of Internal Medicine. 2000;133(11):845–854. [PubMed: 11103054]

Fernandez Perez ER, Winters JL, Gajic O. The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit. American Journal of Hematology. 2007;82(7):631–633. [PubMed: 17236185]

Fisher MR, Topley E. The illness of trauma. British Journal of Clinical Practice. 1956;10(11):770–776. [PubMed: 13374186]

Fitzgerald M, Hodgkinson B, Thorp D. Blood transfusion from the recipient's perspective. Journal of Clinical Nursing. 1999;8(5):593–600. [PubMed: 10786533]

Fortune JB, Feustel PJ, Saifi J, Stratton HH, Newell JC, Shah DM. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. Journal of Trauma. 1987;27(3):243–249. [PubMed: 3560265]

Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009;49(2):227–234. [PubMed: 19389209]

Friedman M, Arja W, Batra R, Daniel S, Hoehn D, Paniz AM, et al. Informed consent for blood transfusion: what do medicine residents tell? What do patients understand? American Journal of Clinical Pathology. 2012;138(4):559–565. [PubMed: 23010711]

Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. Journal of Arthroplasty. 2004;19(4):488–492. [PubMed: 15188109]

Garrido-Martin P, Nassar-Mansur MI, de la Llana-Ducros R, Virgos-Aller TM, Rodriguez Fortunez PM, Avalos-Pinto R, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interactive Cardiovascular and Thoracic Surgery. 2012;15(6):1013–1018. [PMC free article: PMC3501294] [PubMed: 22940889]

Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. Journal of Arthroplasty. 2013;28(8 Suppl):78–82. [PubMed: 23906869]

Ghaffari Nejad MH, Baharestani B, Esfandiari R, Hashemi J, Panahipoor A. Evaluation and comparison of using low-dose aprotinin and tranexamic acid in CABG: a double blind randomized clinical trial. Journal of Tehran Heart Center. 2012;7(1):15–18. [PMC free article: PMC3466883] [PubMed: 23074629]

Gill JB, Chase E, Rosenstein AD. The use of tranexamic acid in revision total hip arthroplasty: a pilot study. Current Orthopaedic Practice. 2009;20(2):152–156. United States.

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. Journal of Arthroplasty. 2013;28(8 Suppl):137–139. [PubMed: 23886409]

Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. British Journal of Anaesthesia. 2003;90(5):596–599. [PubMed: 12697586]

Goodnough LT, Murphy MF. Do liberal blood transfusions cause more harm than good? BMJ (Clinical Research Ed ). 2014;349:g6897. [PubMed: 25501327]

Goodnough LT, Shah N. The next chapter in patient blood management: real-time clinical decision support. American Journal of Clinical Pathology. 2014;142:741–747. [PubMed: 25389326]

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion. 2014;54(10 Pt 2):2753–2759. [PubMed: 24995770]

Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sanguinis. 2006;90(2):105–112. [PubMed: 16430668]

Gungorduk K, Yildirim G, Asicioglu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. American Journal of Perinatology. 2011;28(3):233–240. [PubMed: 20979013]

Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559–1567. [PubMed: 20940381]

Hardy JF, Belisle S, Dupont C, Harel F, Robitaille D, Roy M, et al. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. Annals of Thoracic Surgery. 1998;65(2):371–376. [PubMed: 9485231]

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New England Journal of Medicine. 1999;340(6):409–417. [PubMed: 9971864]

Hebert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, et al. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group. JAMA. 1995;273(18):1439–1444. [PubMed: 7723158]

Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. Journal of Clinical Oncology. 1997;15(3):1143–1149. [PubMed: 9060557]

Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, et al. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood. 2009;113(7):1564–1573. [PubMed: 19109560]

Heiss MM, Tarabichi A, Delanoff C, Allgayer H, Jauch KW, Hernandez-Richter T, et al. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study. Surgery. 1996;119(5):523–527. [PubMed: 8619207]

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2011;(3) CD001886. [PMC free article: PMC4234031] [PubMed: 21412876]

Hibbs SP, Noel S, Miles D, Staves J, Murphy MF. The impact of electronic decision support and electronic remote blood issue on transfusion practice. Transfusion Medicine. 2014;24(5):274–279. [PubMed: 25186089]

Hiippala S, Strid L, Wennerstrand M, Arvela V, Mantyla S, Ylinen J, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. British Journal of Anaesthesia. 1995;74(5):534–537. [PubMed: 7772427]

Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemela HM, Mantyla SK, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesthesia and Analgesia. 1997;84(4):839–844. [PubMed: 9085968]

Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA, et al. Cryoprecipitate use in the PROMMTT study. Journal of Trauma and Acute Care Surgery. 2013;75(1 Suppl 1):S31–S39. [PMC free article: PMC3736696] [PubMed: 23778509]

Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. New England Journal of Medicine. 2014;371(15):1381–1391. [PubMed: 25270275]

Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation. 1991;84(5):2063–2070. [PubMed: 1934382]

Horstmann WG, Swierstra MJ, Ohanis D, Castelein RM, Kollen BJ, Verheyen CCPM. Reduction of blood loss with the use of a new combined intra-operative and post-operative autologous blood transfusion system compared with no drainage in primary total hip replacement. Bone and Joint Journal. 2013;95-B(5):616–622. [PubMed: 23632670]

Horstmann W, Kuipers B, Ohanis D, Slappendel R, Kollen B, Verheyen C. Autologous re-transfusion drain compared with no drain in total knee arthroplasty: a randomised controlled trial. Blood Transfusion. 2014;12(Suppl 1):s176–s181. [PMC free article: PMC3934246] [PubMed: 24120589]

Horstmann WG, Swierstra MJ, Ohanis D, Rolink R, Kollen BJ, Verheyen CCPM. Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. International Orthopaedics. 2014;38(1):13–18. [PMC free article: PMC3890134] [PubMed: 24077886]

Husted H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthopaedica Scandinavica. 2003;74(6):665–669. [PubMed: 14763696]

Irisson E, Hemon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthopaedics and Traumatology: Surgery and Research. 2012;98(5):477–483. France. [PubMed: 22854336]

Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. International Orthopaedics. 2011;35(11):1639–1645. [PMC free article: PMC3193960] [PubMed: 21253725]

Jabalameli M, Zakeri K. Evaluation of topical tranexamic acid on intraoperative bleeding in endoscopic sinus surgery. Iranian Journal of Medical Sciences. 2006;31(4):221–223.

Jairath V, Kahan BC, Gray A, Dore CJ, Mora A, James MW, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet (London, England). 2015;386(9989):137–144. [PubMed: 25956718]

Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. British Journal of Anaesthesia. 1999;83(4):596–601. [PubMed: 10673876]

Jares M, Vanek T, Straka Z, Brucek P. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. Journal of Cardiovascular Surgery. 2003;44(2):205–208. [PubMed: 12813384]

Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Critical Care. 2007;11(6):R117. [PMC free article: PMC2246206] [PubMed: 17988379]

Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthopaedica. 2005;76(3):314–319. [PubMed: 16156456]

Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. Journal of Thoracic and Cardiovascular Surgery. 1992;104(2):307–314. [PubMed: 1495291]

Joint Formulary Committee. 67 British National Formulary (BNF). 63rd edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2014. Available from: http://www​.bnf.org.uk.

Kaewpradub P, Apipan B, Rummasak D. Does tranexamic acid in an irrigating fluid reduce intraoperative blood loss in orthognathic surgery? A double-blind, randomized clinical trial. Journal of Oral and Maxillofacial Surgery. 2011;69(6):e186–e189. [PubMed: 21398011]

Karam O, Tucci M, Combescure C, Lacroix J, Rimensberger PC. Plasma transfusion strategies for critically ill patients. Cochrane Database of Systematic Reviews. 2013;(12) CD010654. [PubMed: 24374651]

Karam O, Tucci M, Ducruet T, Hume HA, Lacroix J, Gauvin F, et al. Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatric Critical Care Medicine. 2011;12(5):512–518. [PubMed: 21057356]

Karimi A, Mohammadi SS, Hasheminasab M. Efficacy of tranexamic acid on blood loss during bimaxilary osteotomy: A randomized double blind clinical trial. Saudi Journal of Anaesthesia. 2012;6(1):41–45. [PMC free article: PMC3299114] [PubMed: 22412776]

Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Canadian Journal of Anaesthesia. 2006;53(1):11–19. [PubMed: 16371604]

Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. Journal of Thoracic and Cardiovascular Surgery. 2005;130(2):309–314. [PubMed: 16077392]

Kateros K, Sakellariou VI, Sofianos IP, Papagelopoulos PJ. Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. Journal of Critical Care. 2010;25(2):348–353. [PubMed: 19592206]

Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations. Journal of Thoracic and Cardiovascular Surgery. 1997;113(4):802–804. [PubMed: 9104995]

Katsaros D, Petricevic M, Snow NJ, Woodhall DD, Van Bergen R. Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. Annals of Thoracic Surgery. 1996;61(4):1131–1135. [PubMed: 8607670]

Kazemi SM, Mosaffa F, Eajazi A, Kaffashi M, Besheli LD, Bigdeli MR, et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics. 2010;33(1):17. [PubMed: 20055345]

Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology. 2011;154(3):311–324. [PubMed: 21671894]

Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. British Journal of Surgery. 2013;100(10):1271–1279. [PubMed: 23839785]

Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database of Systematic Reviews. 2013;(7) CD010562. [PubMed: 23881695] [CrossRef]

Kerebel D, Joly L-M, Honnart D, Schmidt J, Galanaud D, Negrier C, et al. A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal. Critical Care. 2013;17(1) [PMC free article: PMC4057510] [PubMed: 23305460]

Kettelhack C, Hones C, Messinger D, Schlag PM. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. British Journal of Surgery. 1998;85(1):63–67. [PubMed: 9462386]

Khorsand N, Veeger NJGM, Hest RM, Ypma PF, Heidt J, Meijer K. An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin k antagonists in 240 bleeding emergencies. Haematologica. 2012;97(10):1501–1506. [PMC free article: PMC3487550] [PubMed: 22491734]

Kim TK, Chang CB, Kang YG, Seo ES, Lee JH, Yun JH, et al. Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy. 2014;22(8):1870–1878. [PubMed: 23592025]

Kim YH, Chung HH, Kang SB, Kim SC, Kim YT. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. Acta Haematologica. 2009;121(1):37–41. [PubMed: 19332985]

Klein AA, Nashef SAM, Sharples L, Bottrill F, Dyer M, Armstrong J, et al. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesthesia and Analgesia. 2008;107(5):1487–1495. [PubMed: 18931203]

Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, et al. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion. 1999;39(7):674–681. [PubMed: 10413273]

Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Annals of Surgery. 2003;237(3):417–421. [PMC free article: PMC1514310] [PubMed: 12616127]

Krohn CD, Sorensen R, Lange JE, Riise R, Bjornsen S, Brosstad F. Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery. European Journal of Surgery Supplement. 2003;(588):57–61. [PubMed: 15200045]

Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenpera M. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Acta Anaesthesiologica Scandinavica. 2005;49(9):1272–1279. [PubMed: 16146463]

Lacroix J, Hebert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. New England Journal of Medicine. 2007;356(16):1609–1619. [PubMed: 17442904]

Larson B, Bremme K, Clyne N, Nordstrom L. Preoperative treatment of anemic women with epoetin beta. Acta Obstetricia Et Gynecologica Scandinavica. 2001;80(6):559–562. [PubMed: 11380294]

Later AFL, Maas JJ, Engbers FHM, Versteegh MIM, Bruggemans EF, Dion RAE, et al. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. European Journal of Cardio-Thoracic Surgery. 2009;36(2):322–329. [PubMed: 19250838]

Laupacis A. Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgery. Seminars in Hematology. 1996;33(2 Suppl 2):51–54. [PubMed: 8723583]

Leal-Noval SR, Lopez-Irizo R, Bautista-Paloma J, Casado M, Arellano-Orden V, Leal-Romero M, et al. Efficacy of the prothrombin complex concentrate prothromplex in patients requiring urgent reversal of vitamin K antagonists or presenting with uncontrolled bleeding: A retrospective, single center study. Blood Coagulation and Fibrinolysis. 2013;24(8):862–868. [PubMed: 24060736]

Lee BW, Park MG, Cho DY, Park SS, Yeo JK. Preoperative erythropoietin administration in patients with prostate cancer undergoing radical prostatectomy without transfusion. Korean Journal of Urology. 2014;55(2):102–105. [PMC free article: PMC3935065] [PubMed: 24578805]

Lee SH, Lee SM, Kim CS, Cho HS, Lee J-H, Lee CH, et al. Fibrinogen recovery and changes in fibrin-based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest. Transfusion. 2014;54(5):1379–1387. [PubMed: 24192484]

Lee YC, Park SJ, Kim JS, Cho CH. Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. Journal of Clinical Anesthesia. 2013;25(5):393–398. [PubMed: 23965206]

Lemay E, Guay J, Cote C, Roy A. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Canadian Journal of Anaesthesia. 2004;51(1):31–37. [PubMed: 14709457]

Lidder PG, Sanders G, Whitehead E, Douie WJ, Mellor N, Lewis SJ, et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial. Annals of the Royal College of Surgeons of England. 2007;89(4):418–421. [PMC free article: PMC1963583] [PubMed: 17535624]

Lin YC, Chang CS, Yeh CJ, Wu YC. The appropriateness and physician compliance of platelet usage by a computerized transfusion decision support system in a medical center. Transfusion. 2010;50(12):2565–2570. [PubMed: 20576016]

Lotke PA, Barth P, Garino JP, Cook EF. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. Journal of Arthroplasty. 1999;14(6):647–650. [PubMed: 10512433]

Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, et al. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sanguinis. 2008;95:39–44. [PubMed: 18363576]

Lundin ES, Johansson T, Zachrisson H, Leandersson U, Backman F, Falknas L, et al. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study. Acta Obstetricia Et Gynecologica Scandinavica. 2014;93(4):335–344. [PubMed: 24428857]

Luporsi E, Mahi L, Morre C, Wernli J, de Pouvourville G, Bugat R. Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective. Journal of Medical Economics. 2012;15(2):225–232. [PubMed: 22077267]

MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. Journal of Arthroplasty. 2011;26(1):24–28. [PubMed: 20171048]

Madi-Jebara SN, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2004;18(1):59–63. [PubMed: 14973801]

Mansour EE, Mustafa B. Aprotinin versus tranexamic acid in patients receiving aspirin and undergoing off-pump coronary artery bypass. Egyptian Journal of Anaesthesia. 2004;20(3):229–236.

Markatou M, Theodoraki K, Rizos D, Fassoulaki A. Targeting perioperative hemoglobin in major abdominal surgery. Journal of Anesthesia and Clinical Research. 2012;3(2)

Matsumoto M, Kawa K, Uemura M, Kato S, Ishizashi H, Isonishi A, et al. Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transplantation. 2007;40(3):251–259. [PubMed: 17549054]

Mehr-Aein A, Davoodi S, Madani-Civi M. Effects of tranexamic acid and autotransfusion in coronary artery bypass. Asian Cardiovascular and Thoracic Annals. 2007;15(1):49–53. [PubMed: 17244923]

Menichetti A, Tritapepe L, Ruvolo G, Speziale G, Cogliati A, Di Giovanni C, et al. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. Journal of Cardiovascular Surgery. 1996;37(4):401–407. [PubMed: 8698787]

Mercer KG, Spark JI, Berridge DC, Kent PJ, Scott DJ. Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. British Journal of Surgery. 2004;91(11):1443–1448. [PubMed: 15499651]

Miller K, Akers C, Magrin G, Whitehead S, Davis AK. Piloting the use of 2D barcode and patient safety-software in an Australian tertiary hospital setting. Vox Sanguinis. 2013;105(2):159–166. [PubMed: 23600799]

Miyata S, Kawai T, Yamamoto S, Takada M, Iwatani Y, Uchida O, et al. Network computer-assisted transfusion-management system for accurate blood component-recipient identification at the bedside. Transfusion. 2004;44(3):364–372. [PubMed: 14996193]

Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion. 2007;47(3):379–384. [PubMed: 17319816]

Munoz M, Iglesias D, Garcia-Erce JA, Cuenca J, Herrera A, Martin-Montanez E, et al. Utility and cost of low-vacuum reinfusion drains in patients undergoing surgery for subcapital hip fracture repair: a before and after cohort study. Vox Sanguinis. 2014;106(1):83–91. [PubMed: 23869647]

Munoz M, Ariza D, Campos A, Martin-Montanez E, Pavia J. The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. Blood Transfusion. 2013;11(2):260–271. [PMC free article: PMC3626479] [PubMed: 23149145]

Murphy GJ, Allen SM, Unsworth-White J, Lewis CT, Dalrymple-Hay MJ. Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial. Annals of Thoracic Surgery. 2004;77(5):1553–1559. [PubMed: 15111142]

Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. New England Journal of Medicine. 2015;372(11):997–1008. [PubMed: 25760354]

Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, et al. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: a randomized trial. Journal of Thoracic and Cardiovascular Surgery. 2005;130(1):20–28. [PubMed: 15999036]

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, et al. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 2006;132(3):475–478. [PubMed: 16935098]

Murphy MF, Docherty S, Greenfield P. Survey of the information given to patients about blood transfusion and the need for consent before transfusion. Transfusion Medicine. 1997;7(4):287–288. [PubMed: 9510926]

Murphy MF, Fraser E, Miles D, Noel S, Staves J, Cripps B, et al. How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system? Transfusion. 2012;52(12):2502–2512. [PubMed: 22230038]

Murphy S, Litwin S, Herring LM, Koch P, Remischovsky J, Donaldson MH, et al. Indications for platelet transfusion in children with acute leukemia. American Journal of Hematology. 1982;12(4):347–356. [PubMed: 6981349]

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion. 2011;51(1):118–124. [PubMed: 20624257]

National Clinical Guideline Centre. Intravenous fluid therapy in adults in hospital. London: National Clinical Guideline Centre; 2013. (NICE clinical guideline 174). Available from: http://www​.nice.org.uk​/guidance/cg174/resources​/guidance-intravenous-fluid-therapy-in-adults-in-hospital-pdf.

National Clinical Guideline Centre. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. London: National Clinical Guideline Centre; 2014. (NICE clinical guideline 182). Available from: http://guidance​.nice.org.uk/CG182.

National Clinical Guideline Centre. Anaemia management in people with chronic kidney disease. London: National Clinical Guideline Centre; 2015. (NICE guideline 8). Available from: https://www​.nice.org.uk/guidance/ng8.

National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems). London: National Institute for Health and Care Excellence (NICE); 2014. (NICE diagnostic guidance 13). Available from: http://guidance​.nice.org.uk/DG13.

National Institute for Health and Care Excellence. Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA142). London: National Institute for Health and Care Excellence; 2014. (NICE technology appraisal guidance 323). Available from: http://guidance​.nice.org.uk/TA323.

National Institute for Health and Clinical Excellence. Social value judgements: principles for the development of NICE guidance. 2nd edition. London: National Institute for Health and Clinical Excellence; 2008. Available from: http://www​.nice.org.uk​/media/C18/30/SVJ2PUBLICATION2008.pdf. [PubMed: 27905706]

National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2012. Available from: http://publications​.nice​.org.uk/the-guidelines-manual-pmg6/ [PubMed: 27905714]

Naumenko SE, Pokrovskii MG, Belavin AS, Kim SF. Blood-saving effectiveness of preoperative reservation of autoblood for surgical treatment of ischemic heart disease. Vestnik Khirurgii Imeni I I Grekova. 2003;162(2):59–64. [PubMed: 14606149]

NHS Blood Transplant. National comparative audit of blood transfusion. 2013. Available from: http://hospital​.blood​.co.uk/audits/national-comparative-audit/

NHS Blood Transplant. Price list 2013/2014. NHS Blood and Transplant; 2013.

NHS Blood Transplant. NHSBT Portfolio of blood components and guidance for their clinical use. 2014. Available from: http://hospital​.blood​.co.uk/media/27048/spn223-v6-2.pdf.

NHS Blood Transplant. Standard cryoprecipitate and methylene blue treated cryoprecipitate factsheet. 2014. Available from: http://hospital​.blood​.co.uk/media/27096/140904-standard-cryoprecipitate-a5-factsheet.pdf.

NHS Blood and Transplant; Royal College of Physcians; Royal College of Nursing. National comparative audit of blood transfusion: 2011 re-audit of bedside transfusion practice. 2011. Available from: http://hospital​.blood​.co.uk/library/pdf/NCA​_2011_bedside_tx_re-audit_report.pdf.

NHS Supply Chain. NHS supply chain catalogue. 2014. [20 February 2015]. Available from: http://www​.supplychain​.nhs.uk/news/company​/april-2014-national-catalogue/

Nielsen K, Dahl B, Johansson PI, Henneberg SW, Rasmussen LS. Intraoperative transfusion threshold and tissue oxygenation: a randomised trial. Transfusion Medicine. 2012;22(6):418–425. [PubMed: 23121563]

Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthopaedica. 2005;76(6):829–832. [PubMed: 16470437]

Noddeland H, Tollofsrud S, Svennevig J, Bentsen G, Brosstad F, Solheim B. Universal solvent/detergent-treated fresh frozen plasma (Uniplas--rationale and clinical properties. Thrombosis Research. 2002;107(Suppl 1):S33–S37. [PubMed: 12379291]

Nouraei M, Gholipour BA, Ghafari R, Habibi MR, Emami ZA, Sharifi N. Decreasing blood loss and the need for transfusion after CABG surgery: A double-blind randomized clinical trial of topical tranexamic acid. Turkish Journal of Medical Sciences. 2013;43(2):273–278.

Novis DA, Miller KA, Howanitz PJ, Renner SW, Walsh MK., College of American Pathologists. Audit of transfusion procedures in 660 hospitals. A College of American Pathologists Q-Probes study of patient identification and vital sign monitoring frequencies in 16494 transfusions. Archives of Pathology and Laboratory Medicine. 2003;127(5):541–548. [PubMed: 12708895]

Nuttall GA, Abenstein JP, Stubbs JR, Santrach P, Ereth MH, Johnson PM, et al. Computerized bar code-based blood identification systems and near-miss transfusion episodes and transfusion errors. Mayo Clinic Proceedings Mayo Clinic. 2013;88(4):354–359. [PubMed: 23541010]

Ohsaka A, Abe K, Ohsawa T, Miyake N, Sugita S, Tojima I. A computer-assisted transfusion management system and changed transfusion practices contribute to appropriate management of blood components. Transfusion. 2008;48(8):1730–1738. [PubMed: 18482189]

Olijhoek G, Megens JG, Musto P, Nogarin L, Gassmann-Mayer C, Vercammen E, et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion. 2001;41(7):957–963. [PubMed: 11452166]

Oremus K, Sostaric S, Trkulja V, Haspl M. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion. 2014;54(1):31–41. [PubMed: 23614539]

Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP). 2013. [7 June 2012]. Available from: http://www​.oecd.org/std/ppp.

Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP). 2013. [7 June 2012]. Available from: http://www​.oecd.org/std/ppp.

Orpen NM, Little C, Walker G, Crawfurd EJP. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee. 2006;13(2):106–110. [PubMed: 16487712]

Oxford University Hospitals. Electronic blood transfusion:Improving safety and efficiency of transfusion systems. Oxford University Hospitals; 2013. Available from: https://www​.evidence​.nhs.uk/document?ci=http%3A%2F%2Farms​.evidence​.nhs.uk%2Fresources​%2FQIPP%2F29453&q​=transfusion&ReturnUrl=​%2Fsearch%3Fom%3D%255B​%257B%2522srn%2522​%253A%255B%2522%2Bqipp​%2B%2522%255D%257D​%255D%26q%3Dtransfusion.

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. Journal of Thrombosis and Haemostasis. 2008;6(4):622–631. [PubMed: 18208533]

Pagliaro P, Turdo R, Capuzzo E. Patients' positive identification systems. Blood Transfusion. 2009;7(4):313–318. [PMC free article: PMC2782809] [PubMed: 20011643]

Palmieri TL, Lee T, O'Mara MS, Greenhalgh DG. Effects of a restrictive blood transfusion policy on outcomes in children with burn injury. Journal of Burn Care and Research. 2007;28(1):65–70. United States. [PubMed: 17211202]

Panchmatia JR, Chegini S, Lobban C, Shah G, Stapleton C, Smallman JM, et al. The routine use of tranexamic acid in hip and knee replacements. Bulletin of the NYU Hospital for Joint Diseases. 2012;70(4):246–249. United Kingdom. [PubMed: 23267449]

Park SH, Nam E, Bang SM, Cho EK, Shin DB, Lee JH. A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 2008;62(1):1–9. [PubMed: 17690882]

Parker MJ. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. Journal of Bone and Joint Surgery American Volume. 2010;92(2):265–269. [PubMed: 20124051]

Parris E, Grant-Casey J. Promoting safer blood transfusion practice in hospital. Nursing Standard. 2007;21(41):35–38. [PubMed: 17633340]

Pentti J, Syrjala M, Pettila V. Computerized quality assurance of decisions to transfuse blood components to critically ill patients. Acta Anaesthesiologica Scandinavica. 2003;47(8):973–978. [PubMed: 12904189]

Perel P, Ker K, Morales Uribe CH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database of Systematic Reviews. 2013;(1) CD010245. [PMC free article: PMC8925276] [PubMed: 23440847]

Pinheiro de Almeida J, Vincent JL, Barbosa Gomes Galas FR, Pinto Marinho de Almeida E, Fukushima JT, Osawa EA, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology. 2015;122:29–38. [PubMed: 25401417]

Pleym H, Tjomsland O, Asberg A, Lydersen S, Wahba A, Bjella L, et al. Effects of autotransfusion of mediastinal shed blood on biochemical markers of myocardial damage in coronary surgery. Acta Anaesthesiologica Scandinavica. 2005;49(9):1248–1254. [PubMed: 16146460]

Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesthesia and Analgesia. 2003;96(4):923–928. [PubMed: 12651635]

Podesta A, Carmagnini E, Parodi E, Dottori V, Crivellari R, Barberis L, et al. Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha). Minerva Cardioangiologica. 2000;48(11):341–347. [PubMed: 11214425]

Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery - prospective double-blind placebo-controlled study. World Journal of Surgery. 1999;23:30–35. [PubMed: 9841760]

Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. Journal of Bone and Joint Surgery British Volume. 2009;91(6):776–783. [PubMed: 19483232]

Rana R, Afessa B, Keegan MT, Whalen FXJ, Nuttall GA, Evenson LK, et al. Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry. Critical Care Medicine. 2006;34(7):1892–1897. [PubMed: 16691136]

Rannikko A, Petas A, Taari K. Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology. 2004;64(5):955–958. [PubMed: 15533485]

Rao VK, Dyga R, Bartels C, Waters JH. A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty. Transfusion. 2012;52(8):1750–1760. [PMC free article: PMC3360121] [PubMed: 22339139]

Raviraj A, Anand A, Chakravarthy M, Kumarswamy S, Prabhu A, Pai S. Tranexamic acid reduces blood loss in simultaneous bilateral total knee arthroplasty: a randomized control trial. European Journal of Orthopaedic Surgery and Traumatology. 2012;22(5):381–386.

Razavi SA, Carter AB, Puskas JD, Gregg SR, Aziz IF, Buchman TG. Reduced red blood cell transfusion in cardiothoracic surgery after implementation of a novel clinical decision support tool. Journal of the American College of Surgeons. 2014;219:1028–1036. [PubMed: 25026877]

Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. New England Journal of Medicine. 1997;337(26):1870–1875. [PubMed: 9407153]

Reyes G, Prieto M, Alvarez P, Orts M, Bustamante J, Santos G, et al. Cell saving systems do not reduce the need of transfusion in low-risk patients undergoing cardiac surgery. Interactive Cardiovascular and Thoracic Surgery. 2011;12(2):189–193. [PubMed: 21118833]

Riley W, Smalley B, Pulkrabek S, Clay ME, McCullough J. Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies. Transfusion. 2012;52(9):1957–1967. [PubMed: 22320153]

Rollo VJ, Hozack WJ, Rothman RH, Chao W, Eng KO. Prospective randomized evaluation of blood salvage techniques for primary total hip arthroplasty. Journal of Arthroplasty. 1995;10(4):532–539. [PubMed: 8523015]

Rothschild JM, McGurk S, Honour M, Lu L, McClendon AA, Srivastava P, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007;47(2):228–239. [PubMed: 17302768]

Roy SP, Tanki UF, Dutta A, Jain SK, Nagi ON. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy. 2012;20(12):2494–2501. [PubMed: 22419263]

Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V, Woratanarat P, Chanplakorn P, Wibulpolprasert B, et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthopedic Reviews. 2011;3(2):e12. [PMC free article: PMC3206515] [PubMed: 22053253]

Sa-Ngasoongsong P, Wongsak S, Chanplakorn P, Woratanarat P, Wechmongkolgorn S, Wibulpolprasert B, et al. Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. BMC Musculoskeletal Disorders. 2013;14:340. [PMC free article: PMC4234192] [PubMed: 24308672]

Sadeghi M, Mehr-Aein A. Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica. 2007;45(6):437–442.

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM. Economic evaluation of cell salvage in pediatric surgery. Paediatric Anaesthesia. 2013;23(11):1027–1034. [PubMed: 23952976]

Sankar D, Krishnan R, Veerabahu M, Vikraman B. Evaluation of the efficacy of tranexamic acid on blood loss in orthognathic surgery. A prospective, randomized clinical study. International Journal of Oral and Maxillofacial Surgery. 2012;41(6):713–717. [PubMed: 22340993]

Santos ATL, Kalil RAK, Bauemann C, Pereira JB, Nesralla IA. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Brazilian Journal of Medical and Biological Research. 2006;39(1):63–69. [PubMed: 16400465]

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C. Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. Transfusion. 2010;50(2):487–492. [PubMed: 19804569]

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG. Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. Transfusion Medicine. 2009;19(4):202–206. [PubMed: 19706137]

Scheurer DB, Roy CL, McGurk S, Kachalia A. Effectiveness of computerized physician order entry with decision support to reduce inappropriate blood transfusions. Journal of Clinical Outcomes Management. 2010;17(1):17–26.

Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope. 2002;112(7 Pt 1):1221–1229. [PubMed: 12169903]

Sensebe L, Giraudeau B, Bardiaux L, Deconinck E, Schmidt A, Bidet ML, et al. The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood. 2005;105(2):862–864. [PubMed: 15367427]

Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy. 2013;21(8):1869–1874. [PubMed: 22729012]

Serrano-Trenas JA, Ugalde PF, Cabello LM, Chofles LC, Lazaro PS, Benitez PC. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion. 2011;51(1):97–104. [PubMed: 20630042]

Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102(4):727–732. [PubMed: 15791100]

Shahid A, Khan A. Tranexamic acid in decreasing blood loss during and after caesarean section. Journal of the College of Physicians and Surgeons--Pakistan. 2013;23(7):459–462. [PubMed: 23823946]

Shehata N, Burns LA, Nathan H, Hebert P, Hare GMT, Fergusson D, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion. 2012;52(1):91–99. [PubMed: 21790621]

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, et al. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surgery. 2013;148(6):538–547. [PubMed: 23426385]

Shi J, Wang G, Lv H, Yuan S, Wang Y, Ji H, et al. Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up. Annals of Thoracic Surgery. 2013;95(3):795–802. [PubMed: 22959576]

Sirvinskas E, Veikutiene A, Benetis R, Grybauskas P, Andrejaitiene J, Veikutis V, et al. Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery. Perfusion. 2007;22(5):345–352. [PubMed: 18416221]

Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. New England Journal of Medicine. 2010;362(7):600–613. [PMC free article: PMC2951321] [PubMed: 20164484]

Smith LK, Williams DH, Langkamer VG. Post-operative blood salvage with autologous retransfusion in primary total hip replacement. Journal of Bone and Joint Surgery British Volume. 2007;89(8):1092–1097. [PubMed: 17785752]

So-Osman C, Nelissen R, Slaa R, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sanguinis. 2010;98(1):56–64. [PubMed: 19656349]

So-Osman C, Nelissen RG, Eikenboom HC, Brand A. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: A randomized pilot study. Transfusion Medicine. 2006;16(5):321–328. [PubMed: 16999754]

So-Osman C, Nelissen RGHH, Koopman-van Gemert AWMM, Kluyver E, Poll RG, Onstenk R, et al. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anesthesiology. 2014;120(4):852–860. [PubMed: 24434302]

Sorin A, Claeys MA, Jansen A, D'Haese J, Camu F. Reduction of blood loss by tranexamic acid in total knee replacement. Journal of Bone and Joint Surgery British Volume. 1999;81-B(Suppl II):234.

Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, et al. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood. 1997;89(2):411–418. [PubMed: 9002942]

Speekenbrink RG, Vonk AB, Wildevuur CR, Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Annals of Thoracic Surgery. 1995;59(2):438–442. [PubMed: 7531423]

St.Elsewhere's NHS Trust. 2010 Re-audit of the use of platelets in haematology. 2011. Available from: http://hospital​.blood​.co.uk/media/26866/nca-platelet​_re-audit​_report-st_elsewheres​_nhs_foundation_trust_2010.pdf.

Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D. A national study of plasma use in critical care: Clinical indications, dose and effect on prothrombin time. Critical Care. 2011;15(2):R108. [PMC free article: PMC3219386] [PubMed: 21466676]

Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. New England Journal of Medicine. 2013;368(19):1771–1780. [PubMed: 23656642]

Stowell CP, Jones SC, Enny C, Langholff W, Leitz G. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine. 2009;34(23):2479–2485. [PubMed: 19927096]

Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T. Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. Journal of Bone and Joint Surgery British Volume. 2004;86(1):31–33. [PubMed: 14765861]

Taghaddomi RJ, Mashhadinezhad H, Attar ARS, Peivandi A. The effect of intravenous tranexamic acid on blood loss in lumbar hernial disc resection under inhalation and total intravenous anesthesia. Iranian Red Crescent Medical Journal. 2009;11(3):265–270.

Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. Journal of Bone and Joint Surgery British Volume. 2001;83(5):702–705. [PubMed: 11476309]

Taylor CJC, Murphy MF, Lowe D, Pearson M. Changes in practice and organisation surrounding blood transfusion in NHS trusts in England 1995-2005. Quality & Safety in Health Care. 2008;17(4):239–243. [PubMed: 18678718]

Thomassen BJW, den Hollander PHC, Kaptijn HH, Nelissen RGHH, Pilot P. Autologous wound drains have no effect on allogeneic blood transfusions in primary total hip and knee replacement: a three-arm randomised trial. Bone and Joint Journal. 2014;96-B(6):765–771. [PubMed: 24891576]

Thomassen BJW, Pilot P, Scholtes VAB, Grohs JG, Holen K, Bisbe E, et al. Limit allogeneic blood use with routine re-use of patient's own blood: a prospective, randomized, controlled trial in total hip surgery. PloS One. 2012;7(9):e44503. [PMC free article: PMC3441549] [PubMed: 23028549]

Tinegate H, Chattree S, Iqbal A, Plews D, Whitehead J, Wallis JP. Ten-year pattern of red blood cell use in the North of England. Transfusion. 2013;53(3):483–489. [PubMed: 22803573]

Tinegate H, Pendry K, Murphy M. Where do all the red cells go? Results of a survey of red cell use in England and North Wales in 2014. Transfusion. 2015. (in press) [PubMed: 26442481]

Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. 2012. Available from: http://www​.bcshguidelines​.com/documents/ATR​_final_version_to_pdf.pdf. [PubMed: 22928769]

Tinmouth A, Tannock IF, Crump M, Tomlinson G, Brandwein J, Minden M, et al. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion. 2004;44(12):1711–1719. [PubMed: 15584985]

Tomeczkowski J, Stern S, Muller A, von Heymann C. Potential cost saving of epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model. PloS One. 2013;8(9):e72949. [PMC free article: PMC3767728] [PubMed: 24039829]

Trimble AS, Osborn JJ, Kerth WJ, Gerbode F. The prophylactic use of fresh frozen plasma after extracoporeal circulation. Journal of Thoracic and Cardiovascular Surgery. 1964;48:314–316. [PubMed: 14205066]

Tripkovic B, Bukovic D, Sakic K, Sakic S, Bukovic N, Radakovic B. Quality of the blood sampled from surgical drainage after total hip arthroplasty. Collegium Antropologicum. 2008;32(1):153–160. [PubMed: 18494201]

Tsuji Y, Kambayashi J, Shiba E, Sakon M, Kawasaki T, Mori T. Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study. European Journal of Surgery. 1995;161(1):29–33. [PubMed: 7727602]

Tsutsumimoto T, Shimogata M, Ohta H, Yui M, Yoda I, Misawa H. Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: a prospective randomized study. Spine. 2011;36(23):1913–1918. [PubMed: 21289587]

Turner CL, Casbard AC, Murphy MF. Barcode technology: its role in increasing the safety of blood transfusion. Transfusion. 2003;43(9):1200–1209. [PubMed: 12919421]

University of Bristol. Multi-parameter evidence synthesis research. 2015. [9 March 2015]. Available from: http://www​.bris.ac.uk​/social-community-medicine​/projects/mpes/

Uriz MJ, Antelo ML, Zalba S, Ugalde N, Pena E, Corcoz A. Improved traceability and transfusion safety with a new portable computerised system in a hospital with intermediate transfusion activity. Blood Transfusion. 2011;9(2):172–181. [PMC free article: PMC3096861] [PubMed: 21251464]

van Aart L, Eijkhout HW, Kamphuis JS, Dam M, Schattenkerk ME, Schouten TJ, et al. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thrombosis Research. 2006;118(3):313–320. [PubMed: 16182346]

Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, et al. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). European Journal of Cardio-Thoracic Surgery. 2005;28(4):563–568. [PubMed: 16125959]

Verma K, Errico T, Diefenbach C, Hoelscher C, Peters A, Dryer J, et al. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial. Journal of Bone and Joint Surgery American Volume. 2014;96(10):e80. [PubMed: 24875032]

Vermeijden WJ, Van Klarenbosch J, Gu YJ, Mariani MA, Buhre WF, Scheeren TWL, et al. Effects of cell-saving devices and filters on transfusion in cardiac surgery: A multicenter randomized study. Annals of Thoracic Surgery. 2015;99(1):26–32. [PubMed: 25440265]

Vigna-Taglianti F, Basso L, Rolfo P, Brambilla R, Vaccari F, Lanci G, et al. Tranexamic acid for reducing blood transfusions in arthroplasty interventions: a cost-effective practice. European Journal of Orthopaedic Surgery and Traumatology. 2014;24(4):545–551. [PubMed: 23633085]

Vijay BS, Bedi V, Mitra S, Das B. Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi Journal of Anaesthesia. 2013;7(1):29–32. [PMC free article: PMC3657919] [PubMed: 23717228]

Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine. 2013;368(1):11–21. [PubMed: 23281973]

Vitale MG, Roye BD, Ruchelsman DE, Roye DP. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes. Spine Journal. 2007;7(3):292–300. United States. [PubMed: 17482112]

Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Critical Care Medicine. 2013;41(10):2354–2363. [PubMed: 23939351]

Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, Wyncoll D, et al. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Critical Care Medicine. 2010;38(10):1939–1946. [PubMed: 20639745]

Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet. 2012;380(9850):1309–1316. [PubMed: 22877506]

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, et al. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesia and Analgesia. 2012;115(2):239–243. [PubMed: 21737704]

Weatherall M, Maling TJ. Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial. ANZ Journal of Surgery. 2004;74(12):1049–1051. [PubMed: 15574145]

Weber EWG, Slappendel R, Hemon Y, Mahler S, Dalen T, Rouwet E, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). European Journal of Anaesthesiology. 2005;22(4):249–257. [PubMed: 15892401]

Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 2008;48(1):81–91. [PubMed: 17894791]

Wei M, Jian K, Guo Z, Wang L, Jiang D, Zhang L, et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scandinavian Cardiovascular Journal. 2006;40(2):105–109. [PubMed: 16608780]

Wells AW, Llewelyn CA, Casbard A, Johnson AJ, Amin M, Ballard S, et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfusion Medicine. 2009;19(6):315–328. [PubMed: 19735383]

Weltert L, D'Alessandro S, Nardella S, Girola F, Bellisario A, Maselli D, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. Journal of Thoracic and Cardiovascular Surgery. 2010;139(3):621–626. [PubMed: 20042202]

Wiefferink A, Weerwind PW, van Heerde W, Teerenstra S, Noyez L, de Pauw BE, et al. Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements. Journal of Extra-Corporeal Technology. 2007;39(2):66–70. [PMC free article: PMC4680668] [PubMed: 17672185]

Wikkelsø A, Lunde J, Johansen M, Stensballe J, Wetterslev J, Møller AM, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database of Systematic Reviews. 2013;(8) CD008864. [PMC free article: PMC6517136] [PubMed: 23986527] [CrossRef]

Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. Journal of Bone and Joint Surgery American Volume. 2010;92(15):2503–2513. [PubMed: 21048170]

Wong J, El Beheiry H, Rampersaud YR, Lewis S, Ahn H, De Silva Y, et al. Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesthesia and Analgesia. 2008;107(5):1479–1486. [PubMed: 18931202]

Wu CC, Ho WM, Cheng SB, Yeh DC, Wen MC, Liu TJ, et al. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy. Annals of Surgery. 2006;243(2):173–180. [PMC free article: PMC1448924] [PubMed: 16432349]

Wurnig C, Schatz K, Noske H, Hemon Y, Dahlberg G, Josefsson G, et al. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation. European Surgical Research. 2001;33(5-6):303–310. [PubMed: 11805389]

Yang Y, Lv YM, Ding PJ, Li J, Ying-Ze Z. The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. European Journal of Orthopaedic Surgery and Traumatology. 2014. Epub. [PubMed: 24816760]

Yerrabothala S, Desrosiers KP, Szczepiorkowski ZM, Dunbar NM. Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective computerized order auditing. Transfusion. 2014;54(10 Pt 2):2640–2645. [PubMed: 24673396]

Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115(5):929–937. [PubMed: 22027622]

Yue C, Kang P, Yang P, Xie J, Pei F. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. Journal of Arthroplasty. 2014;29(12):2452–2456. [PubMed: 24793893]

Zacharopoulos A, Apostolopoulos A, Kyriakidis A. The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. International Orthopaedics. 2007;31(3):303–308. [PMC free article: PMC2267590] [PubMed: 16810542]

Zhang XF, Dong JM, Gong ML, Shen SM, Zhou Y, Pan YF, et al. Effectiveness of preoperative autologous plateletpheresis combined with intraoperative autotransfusion on the blood coagulation in orthopaedic patients. Zhonghua Wai Ke Za Zhi. [Chinese Journal of Surgery]. 2008;46(2):118–121. [PubMed: 18509970]

Zhao K, Xu J, Hu S, Wu Q, Wei Y, Liu Y. Autotransfusion of shed mediastinal blood after open heart surgery. Chinese Medical Journal. 2003;116(8):1179–1182. [PubMed: 12935406]

Zilberberg MD, Shorr AF. Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. BMC Health Services Research. 2007;7:138. United States. [PMC free article: PMC2064919] [PubMed: 17764560]

Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesthesia and Analgesia. 2004;99(6):1679–1683. [PubMed: 15562053]

Zonis Z, Seear M, Reichert C, Sett S, Allen C. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery. 1996;111(5):982–987. [PubMed: 8622323]

Zumberg MS, del Rosario ML, Nejame CF, Pollock BH, Garzarella L, Kao KJ, et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biology of Blood and Marrow Transplantation. 2002;8(10):569–576. [PubMed: 12434952]

Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury. Critical Care Medicine. 2009;37(3):1074–1078. [PubMed: 19237920]